Out-Licensing in EMEA
Apotex offers a variety of products to our international partners. Most products are in oral dosage forms — tablets and capsules. Our facilities are EU GMP compliant and we have experience with registrations in most European countries. We also provide flexible terms.
We are continuously investing in R&D, ensuring a bright future for Apotex and our partners. One of our core strengths lies in our vertical integration from formulation, API development, product development to manufacturing.
Currently, we export to over 115 countries and we aim to be competitive in the timing of our launches for our pipeline products.
For a complete list of our products available for licensing to Europe and Middle East please submit your opportunity for our consideration.